Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Tuberous Sclerosis × Cannabidiol × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1 Breast Cancer Female 1

Interventions

ganaxolone 2 Sirolimus 2 Everolimus 2 Melatonin 1 Cannabidiol 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02544750 2022-07-14

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Jazz Pharmaceuticals

Phase 3 Completed

199 enrolled 14 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡